Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Wu Capital

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 41
Average round size
info
The average size of a deal this fund participated in
$48M
Portfolio companies 33
Rounds per year 4.10
Lead investments 9
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.20
Exits 4
Key employees 1

Areas of investment

  • Artificial Intelligence
  • Health Care
  • Internet
  • Biotechnology
  • Mobile
Summary

The venture was found in Asia in China. The leading representative office of defined VC is situated in the Beijing.

The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Wu Capital, startups are often financed by ZhenFund, Social Starts, IDG Capital. The meaningful sponsors for the fund in investment in the same round are IDG Capital, Highlight Capital, Lightspeed China Partners. In the next rounds fund is usually obtained by Shunwei Capital, SIG China (SIG Asia Investments), Morningside Venture Capital.

Besides them, we counted 1 critical employee of this fund in our database.

We can highlight the next thriving fund investment areas, such as Artificial Intelligence, Semiconductor. Among the most popular portfolio startups of the fund, we may highlight Horizon Robotics, XiaoHongChun, Yunding Technology. For fund there is a match between the location of its establishment and the land of its numerous investments - China. The fund has no specific favorite in a number of founders of portfolio startups. In case when startup counts 4 of the founder, the chance for it to get the investment is meager. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund.

This Wu Capital works on 22 percentage points less the average amount of lead investments comparing to the other organizations. The top activity for fund was in 2019. The fund is constantly included in 2-6 deals per year. The common things for fund are deals in the range of 10 - 50 millions dollars. Speaking about the real fund results, this VC is 40 percentage points more often commits exit comparing to other organizations. The higher amount of exits for fund were in 2018.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Wu Capital:
Typical Co-investors
Wu Capital is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Wu Capital:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Addidi Angels -
Al Mohallab Kuwait Real Estate Company -
Blackrock Capital LTD -
Capital Group Private Markets Beijing, Beijing, China
Comfort Home China, Shaanxi, Xian Shi
EarlyShares Florida, Miami, United States
Endeit Capital Amsterdam, Noord-Holland, The Netherlands
Founderment Ventures Aarhus, Denmark, Midtjylland
HBS Angels of Boston Boston, Massachusetts, United States
iBelay -
Lorinet Foundation Nassau, The Bahamas
Lotte Homeshopping Seoul, Seoul-t'ukpyolsi, South Korea
Nanjing Securities China, Jiangsu, Nanjing
Raging Bull Texas, Tyler, United States
Sobrato Family Foundation -
Suffolk Holdings -
Tech2b Incubator Austria, Linz, Oberosterreich
Vintage Fund California, Los Angeles, United States
Wellington Capital Management -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Ray Therapeutics

Biotechnology
Therapeutics
$100M16 May 2023 San Diego, California, United States

Rona Therapeutics

Health Care
Medical
Therapeutics
$33M07 Apr 2022 Shanghai, Shanghai, China

Korro Bio

Biotechnology
Pharmaceutical
$116M05 Jan 2022 Cambridge, Massachusetts, United States

RiVAI

Artificial Intelligence
Manufacturing
Semiconductor
23 Sep 2021 Futian District, Guangdong Province, China

Ranok Therapeutics

$40M19 Aug 2021 Hangzhou, Zhejiang, China

Feiliu

Artificial Intelligence
Information Technology
Logistics
Software
$30M31 May 2021 Shanghai, China

Laiye

Apps
Artificial Intelligence
Enterprise
Internet
Mobile
Mobile Apps
Mobile Payments
Natural Language Processing
$50M21 Apr 2021 Dongcheng District, Beijing, China

Inipharm

Biotechnology
Health Care
Pharmaceutical
$35M11 Nov 2020 Seattle, Washington, United States

Korro Bio

Biotechnology
Pharmaceutical
$91M10 Sep 2020 Cambridge, Massachusetts, United States
News
Ranok Therapeutics Secures $40 Million Series B Financing to Advance its Innovative Targeted Protein Degradation Pipeline

– Ranok Therapeutics (Hangzhou) Co. Ltd. secured a $40m Series B funding round denominated in both U.S. dollars and Chinese yuan.
– The financing was led by Lapam Capital and Shanghai Healthcare Capital, with additional participation from Wu Capital, Zhongguancun Kaiyuan Capital and existing investors, and representatives of the new investors will join Ranok’s expanded board of directors.
– To date, Ranok has raised the equivalent of over $50m in funding.

Laiye Raises $50M in Series C+ Funding

– Laiye Raises $50M in Series C+ Funding.
– The round was co-led by the Ping An Global Voyager Fund and Shanghai Artificial Intelligence Industry Equity Investment Fund with participation from Lightspeed China Partners, Lightspeed Venture Partners, Sequoia Capital China and Wu Capital.
– The company intends to expand globally and develop products, enhance its RPA offering with native AI capability, compatibility with more operating systems like Linux and Android, deploy on all major cloud platforms, and recruit top talent.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Wu Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 41
Average round size 48M
Rounds per year 4.10
Peak activity year 2020
Lead investments 9
Follow on index 0.20
Exits 4
Group Appearance index 0.85

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Ray Therapeutics

Biotechnology
Therapeutics
$100M16 May 2023 San Diego, California, United States

Rona Therapeutics

Health Care
Medical
Therapeutics
$33M07 Apr 2022 Shanghai, Shanghai, China

Korro Bio

Biotechnology
Pharmaceutical
$116M05 Jan 2022 Cambridge, Massachusetts, United States

RiVAI

Artificial Intelligence
Manufacturing
Semiconductor
23 Sep 2021 Futian District, Guangdong Province, China

Ranok Therapeutics

$40M19 Aug 2021 Hangzhou, Zhejiang, China

Feiliu

Artificial Intelligence
Information Technology
Logistics
Software
$30M31 May 2021 Shanghai, China

Laiye

Apps
Artificial Intelligence
Enterprise
Internet
Mobile
Mobile Apps
Mobile Payments
Natural Language Processing
$50M21 Apr 2021 Dongcheng District, Beijing, China

Inipharm

Biotechnology
Health Care
Pharmaceutical
$35M11 Nov 2020 Seattle, Washington, United States

Korro Bio

Biotechnology
Pharmaceutical
$91M10 Sep 2020 Cambridge, Massachusetts, United States
Crunchbase icon

Content report

The following text will be sent to our editors: